The Role of the Innate Immune System in Immune Dysregulation following CART |
Children’s Hospital of Philadelphia / Caroline Diorio, MD |
'A' Award Grants |
2023 |
Pennsylvania |
Role of Primary Cilium Signaling and Dynamics in Medulloblastoma Initiation and Progression |
University of Texas Southwestern Medical Center / Saikat Mukhopadhyay, MD/PhD |
'A' Award Grants |
2016 |
Texas |
Turning Killers into THINKers: TME Hostility-Impervious NK Cells for Treating Neuroblastoma and Sarcoma |
Baylor College of Medicine / Robin Parihar, MD/PhD |
'A' Award Grants |
2021 |
Texas |
Engineering the CAR T Cells to Overcome Tumor Derived Immune-Inhibition in Glioblastoma |
Baylor College of Medicine / Meenakshi Hegde, MD |
'A' Award Grants |
2016 |
Texas |
Functional Characterization of RELA Fusion Ependymoma as a Basis for Therapeutic Targeting |
St. Jude Children’s Research Hospital / Stephen Mack, PhD |
'A' Award Grants |
2018 |
Tennessee |
Genetic Susceptibility to Pediatric Osteosarcoma and Interaction with Measures of Childhood Growth |
Duke University / Kyle Walsh, Ph.D. |
'A' Award Grants |
2014 |
North Carolina |
Genetically Modified, Cord Blood Derived Natural Killer Cell Therapy for High Grade Pediatric Brain Tumors |
Children’s Research Institute / Conrad Russell Cruz, MD, PhD |
'A' Award Grants |
2015 |
District of Columbia |
Identifying Rare Genetic Variants Involved in High Risk Pediatric Leukemia Via Pooled Sequencing |
Washington University / Todd Druley, MD, PhD |
'A' Award Grants |
2009 |
Missouri |
BET Bromodomain Inhibition as Epigenetic Therapy in Pediatric Leukemia |
Cold Spring Harbor Laboratory / Christopher Vakoc, MD, PhD |
'A' Award Grants |
2012 |
New York |
Novel Approaches to AML Differentiation Therapy |
Dana-Farber Cancer Institute / Andrew Lane, MD/PhD |
'A' Award Grants |
2017 |
Massachusetts |